Evidence map›Paper›PMID 21199874›Full record

ArticleThe Journal of biological chemistry2011

Study of the thiol/disulfide redox systems of the anaerobe Desulfovibrio vulgaris points out pyruvate:ferredoxin oxidoreductase as a new target for thioredoxin 1.

Laetitia Pieulle, Pierre Stocker, Manon Vinay, Matthieu Nouailler, Nicolas Vita, Gaël Brasseur, Edwige Garcin, Corinne Sebban-Kreuzer, Alain Dolla

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Thioredoxin targets fundamental processes in a methane-producing archaeon, Methanocaldococcus jannaschii.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Laetitia PieulleFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and. Electronic address: pieulle@ibsm.cnrs-mrs.fr.
Pierre Stockerthe Equipe Biosciences iSm2, UMR6263, Case 342, FST Université Paul Cézanne, St. Jérome, 13397 Marseille Cedex 20, France.
Manon VinayFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and.
Matthieu NouaillerFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and.
Nicolas VitaFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and.
Gaël BrasseurFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and.
Edwige GarcinFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and.
Corinne Sebban-KreuzerFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and.
Alain DollaFrom the Laboratoire Interactions et Modulateurs de Réponses, CNRS-UPR3243-IFR88, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex 20 and.
Laboratoire de Chimie · FRLaboratoire de Chimie Bactérienne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfate reducers have developed a multifaceted adaptative strategy to survive against oxidative stresses. Along with this oxidative stress response, we recently characterized an elegant reversible disulfide bond-dependent protective mechanism in the pyruvate:ferredoxin oxidoreductase (PFOR) of various Desulfovibrio species. Here, we searched for thiol redox systems involved in this mechanism. Using thiol fluorescent labeling, we show that glutathione is not the major thiol/disulfide balance-controlling compound in four different Desulfovibrio species and that no other plentiful low molecular weight thiol can be detected. Enzymatic analyses of two thioredoxins (Trxs) and three thioredoxin reductases allow us to propose the existence of two independent Trx systems in Desulfovibrio vulgaris Hildenborough (DvH). The TR1/Trx1 system corresponds to the typical bacterial Trx system. We measured a TR1 apparent K(m) value for Trx1 of 8.9 μM. Moreover, our results showed that activity of TR1 was NADPH-dependent. The second system named TR3/Trx3 corresponds to an unconventional Trx system as TR3 used preferentially NADH (K(m) for NADPH, 743 μM; K(m) for NADH, 5.6 μM), and Trx3 was unable to reduce insulin. The K(m) value of TR3 for Trx3 was 1.12 μM. In vitro experiments demonstrated that the TR1/Trx1 system was the only one able to reactivate the oxygen-protected form of Desulfovibrio africanus PFOR. Moreover, ex vivo pulldown assays using the mutant Trx1(C33S) as bait allowed us to capture PFOR from the DvH extract. Altogether, these data demonstrate that PFOR is a new target for Trx1, which is probably involved in the protective switch mechanism of the enzyme.

Indexed as

AnaerobiosisBacterial ProteinsDesulfovibrio vulgarisDisulfidesMutationNADOxidation-ReductionPyruvate SynthaseReactive Oxygen SpeciesSulfhydryl CompoundsThioredoxinsBacterial ProteinsDisulfidesNADPyruvate SynthaseReactive Oxygen SpeciesSulfhydryl CompoundsThioredoxins

Identifiers

PMID21199874
PMCPMC3048668
OpenAlexW2008826649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.